Successful payment reform in oncology requires a balanced approach. CMS’s proposed rules for Part B drugs amount to a superficial solution.
The 5-year pilot will have twice as many participants as initially anticipated.
The increasing use of quality metrics is changing the economic dynamics between healthcare organizations and cardiologists.
Pursuing performance improvement across the ambulatory enterprise can be particularly daunting for cardiologists.
Oncology practices need to prepare for reimbursement based on quality and the total cost of care.
Partnering with health systems in cost savings initiatives can be financially rewarding for cardiologists.
This column in CardioSource WorldNews discusses the advantages and disadvantages for cardiologists who are considering the adoption of an ASC strategy.
Hospitals are looking for ways to curb unnecessary ED usage, and developing ED “super user” programs is proving to be a beneficial approach.
As organizations pursue clinical integration strategies, many are asking whether they should build or buy clinical services, or align with providers to offer a comprehensive portfolio of services.
Page 3 of 13